TP53 and COVID-19: Network pharmacology suggested that the therapeutic effect of SG on COVID-19 may be related to 15 key ingredients such as quercetin and isoliquiritigenin, core targets such as RELA, TP53 and TNF, and signaling pathways such as NF-κB.